Celsion Corporation Highlighted its PLACCINE Vaccine Platform Technology During Oral Presentation at the World Vaccine Congress

Proprietary, Formulated DNA Plasmid Vaccine Candidate Shows Neutralizing
Activity Against 2 Strains of the COVID-19 Virus

The Goal to Provide Broader Range Protection within a Highly Flexible Platform
Appears to Show Promise

Read more at globenewswire.com